Cancer proteomics: from biomarker discovery to signal pathway profiling.
In the post-genomic era of science, the field of proteomics promises the discovery of new molecular targets for therapy, biomarkers for early detection, and new endpoints for therapeutic efficacy and toxicity. Patient-specific targeted therapeutics with reduced toxicity and increased efficacy, the u...
| Publicado en: | Cancer Journal Vol. 7; no. 1; pp. 69 - 70 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Jan/Feb2001
|
| Acceso en línea: | Ver este registro en EBSCOhost |